Transfusion-transmitted cytomegalovirus: the part-time pathogen

Area of Science:

• Transfusion Medicine
• Virology
• Pediatric Infectious Diseases

Background:

• Viral infections are a known risk associated with blood product transfusions.
• While human immunodeficiency virus (HIV) and hepatitis viruses are screened, Cytomegalovirus (CMV) is more prevalent in donor units.
• CMV infection causes disease in only a subset of transfusion recipients, with pediatric patients, especially premature infants, being particularly vulnerable.

Purpose of the Study:

• To identify patient populations at highest risk for transfusion-transmitted CMV.
• To review current methods for detecting CMV in blood donors.
• To evaluate leuko-depletion techniques for reducing CMV transmission.
• To provide recommendations for managing transfusion-transmitted CMV risk.

Main Methods:

• Literature review focusing on transfusion-transmitted Cytomegalovirus.
• Analysis of patient risk factors for CMV disease post-transfusion.
• Evaluation of diagnostic methods for CMV in blood donors.
• Assessment of leuko-depletion efficacy in reducing CMV.
• Synthesis of current guidelines and recommendations.

Main Results:

• Specific pediatric populations, including premature infants, are identified as high-risk for transfusion-transmitted CMV.
• Various methods exist for CMV detection in blood donors, with varying sensitivities and specificities.
• Leuko-depletion effectively reduces CMV transmission, but complete elimination is challenging.
• Recommendations are provided for targeted use of low-risk CMV blood products.

Conclusions:

• Transfusion-transmitted Cytomegalovirus is a significant concern, especially in immunocompromised and pediatric populations.
• Effective donor screening and leuko-depletion strategies are crucial for mitigating CMV transmission.
• Targeted interventions are necessary to protect vulnerable patients from transfusion-associated CMV disease.